Norway Metagenomics Market Size & Outlook, 2023-2030
Norway metagenomics market, 2018-2030 (US$M)
Related Markets
Norway metagenomics market highlights
- The Norway metagenomics market generated a revenue of USD 23.1 million in 2023 and is expected to reach USD 50.6 million by 2030.
- The Norway market is expected to grow at a CAGR of 11.9% from 2024 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2023.
- Sequencing & Data Analytics Services is the most lucrative product segment registering the fastest growth during the forecast period.
Metagenomics market data book summary
| Market revenue in 2023 | USD 23.1 million |
| Market revenue in 2030 | USD 50.6 million |
| Growth rate | 11.9% (CAGR from 2023 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Sequencing & Data Analytics Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Sequencing & Data Analytics Services, Software |
| Key market players worldwide | Bio-Rad Laboratories Inc, Illumina Inc, PerkinElmer, Thermo Fisher Scientific Inc, Novogene, Promega, Qiagen NV, Takara Bio Inc, Oxford Nanopore Technologies PLC, Roche Holding AG |
Other key industry trends
- In terms of revenue, Norway accounted for 1.1% of the global metagenomics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany metagenomics market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 251.6 million by 2030.
Kits & reagents was the largest segment with a revenue share of 61.47% in 2023. Horizon Databook has segmented the Norway metagenomics market based on kits & reagents, sequencing & data analytics services, software covering the revenue growth of each sub-segment from 2018 to 2030.
The Norwegian Sequencing Centre (NSC) was founded in 2009 to make high-throughput sequencing capabilities available to Norwegian research community. A number of organizations, including Health South-East, the University of Oslo, and the Norwegian Research Council, have provided funding.
Furthermore, in December 2021, Illumina, Inc. announced its support for Norway's Precision Medicine Study. The study aims to evaluate the effectiveness of Comprehensive Genomic Profiling (CGP) based on blood samples for cancer therapy selection.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Metagenomics Market Scope
Metagenomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway metagenomics market size, by product, 2018-2030 (US$M)
Norway Metagenomics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
